Nektar Therapeutics | NKTR - Ebitda


Nektar Therapeutics reported $-31.81M in EBITDA for its fiscal quarter ending in September of 2023.





Ebitda Change Date
Agios Pharmaceuticals USD -120.31M 4.82M Dec/2025
ALKERMES USD 80.26M 20.05M Mar/2026
Alterity Therapeutics Limited AUD -7.72M 2.99M Jun/2023
Amgen USD 5.14B 775M Dec/2025
Baxter International USD -447M 873M Dec/2025
BioCryst Pharmaceuticals USD 51.7M 30.14M Sep/2025
Biogen USD 649.7M 76.5M Mar/2026
Bristol-Myers Squibb USD 2.88B 1.36B Dec/2025
Cara Therapeutics USD -2.39M 3.16M Mar/2025
Cipla INR 9.55B 3B Mar/2026
Dr.Reddys Laboratories INR 6.46B 14.43B Mar/2026
Eisai JPY -335M 30.43B Mar/2026
Eli Lilly USD 12.14B 4.26B Dec/2025
Esperion Therapeutics USD -9.93M 24.99M Sep/2025
Exelixis USD 258.29M 15.43M Mar/2026
Gilead Sciences USD 3.02B 1.01B Dec/2025
GlaxoSmithKline GBP 2.77B 1.65B Mar/2026
Grifols EUR 482.04M 7.04M Sep/2025
Halozyme Therapeutics USD 219.57M 197.66M Mar/2026
Incyte USD 367.97M 46.53M Mar/2026
Ionis Pharmaceuticals USD -200.02M 42.89M Dec/2025
Ironwood Pharmaceuticals USD 81.81M 31.71M Sep/2025
Karyopharm Therapeutics USD -26.2M 1.83M Sep/2024
MacroGenics USD -30.2M 52.15M Mar/2026
Merck USD 6.3B 2.09B Dec/2025
Nektar Therapeutics USD -31.81M 70K Sep/2023
Neurocrine Biosciences USD 193.3M 25.1M Mar/2026
Novartis USD 5.3B 530M Mar/2026
Pfizer USD 5.99B 5.23B Mar/2026
Roche Holding CHF 12.68B 2.36B Jun/2024
Sarepta Therapeutics USD -252.2M 84.16M Dec/2025
Takeda JPY 150.25B 297.88B Mar/2026
Teva Pharmaceutical Industries USD 1.06B 582M Mar/2026
Xencor USD -51.05M 55.28M Dec/2025